Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jinghua Yan and Jufang Wu.
Jinghua Yan
Connection Strength
0.060
Jufang Wu
  1. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study. Antimicrob Agents Chemother. 2021 07 16; 65(8):e0035021.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.